FDA Inspection 1053824 — ABBOTT DIABETES CARE LIMITED
The FDA completed an inspection of ABBOTT DIABETES CARE LIMITED on April 12, 2018 in Witney. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Witney (United Kingdom)
Additional Details
Postmarket Audit Inspections